Tirellizumab+Anlotinib VS Anlotinib for MSS-type CRC

Clinical trial NCT06573424 · COMPLETED

Trial details

NCT number: NCT06573424
Sponsor: fan li
Status: COMPLETED
Study type: OBSERVATIONAL

Colon Cancer Immunotherapy

Start date: 2024-05-01
Primary completion: 2024-07-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.